MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-387

  1. 7,322 Posts.
    lightbulb Created with Sketch. 1281
    No doubt the environment changed from when we started the trial, we got in there and exposed ourselves to this and IMO that is very credible. I am staying put even though we will get hammered on the Nasdaq tonight and this coupled with the usual xmas sell down we could drop below $2 IMO but who really knows could go back above $3 next week.

    Market always over re acts in these circumstances, if any hint of Novartis leaving I will be out, in the mean time will patiently await for some positive out comes. keen to hear from Si and management in next few days to calm things down.

    All the best holders.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.